A global leader in the field of in vitro diagnostics for over 55 years, bioMérieux provides diagnostic solutions (including molecular, microbiology and immunoassay) that determine the source of disease and contamination to improve patient health and ensure consumer safety. The company’s products focus on the diagnosis of infectious diseases. Fast and actionable diagnostics are essential in fighting significant public health issues such as antibiotic resistance, food borne illness, and sepsis.